GDR Genedrive Plc

TIDMGDR

RNS Number : 8820X

Genedrive PLC

29 November 2017

For release: 29 November 2017

genedrive plc ("genedrive" or the "Company")

Result of AGM

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held in Manchester today, all resolutions proposed were duly passed.

- Ends -

For further details please contact:

 
 genedrive plc                    +44 (0)161 989 0245 
 David Budd: CEO 
 Matthew Fowler: CFO 
 
 Peel Hunt LLP                    +44 (0)207 418 8900 
 James Steel 
 Oliver Jackson 
 
 Consilium Strategic 
  Communications                  +44 (0)203 709 5700 
 Chris Gardner 
 Matthew Neal 
 Laura Thornton 
 genedrive@consilium-comms.com 
 

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive(R) platform and MTB/RIF test have been launched in India and a Genedrive(R) HCV test has received CE-IVD Certification.

Further details can be found at: www.genedriveplc.com and www.genedrive.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGBSBDBUBDBGRC

(END) Dow Jones Newswires

November 29, 2017 09:19 ET (14:19 GMT)

Genedrive (LSE:GDR)
Historical Stock Chart
From Mar 2024 to Apr 2024

Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2023 to Apr 2024